BCM
GSK icon

Brasada Capital Management’s GSK GSK Stock Holding History

Brasada Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-262
Closed -$13K – 321
2018
Q3 		$13K Buy
+262
New +$13.3K ﹤0.01% 271

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Brasada Capital Management's GSK Position: Q4 2018 in Review

Brasada Capital Management sold out of GSK (GSK) in Q4 2018, closing a stake of 262 shares — an estimated $13K sold.

Brasada Capital Management first reported a position in GSK in Q3 2018 and held it in 1 quarter. The position peaked at $13K in Q3 2018. 799 funds tracked by Wall St. Rank hold GSK as of Q4 2018.

  • Brasada Capital Management reported no remaining GSK position as of Q4 2018 after selling out during the quarter.
  • Brasada Capital Management sold 262 GSK shares in Q4 2018, an estimated $13K.
  • Brasada Capital Management first reported a position in GSK in Q3 2018 and held it in 1 quarter.
  • Brasada Capital Management's GSK position peaked at $13K in Q3 2018.
  • 799 funds tracked by Wall St. Rank held GSK as of Q4 2018.

Based on Brasada Capital Management's 13F filing for Q4 2018, filed 5 Feb 2019.